CINGAL®

Product Description

CINGAL® is an innovative, dual-action injection specifically designed to provide fast and sustained relief from osteoarthritis-related knee pain. Combining high-quality hyaluronic acid with a powerful corticosteroid, CINGAL® effectively addresses both immediate discomfort and long-term joint lubrication. Delivered conveniently in a single injection, this professional-grade product offers healthcare providers a reliable and minimally invasive solution to manage osteoarthritis symptoms and improve patient quality of life.

CINGAL® Dosage and Administration

CINGAL® is available in:

• A single-use, prefilled syringe containing 4 ml of injectable solution.

Administration guidelines:

• Injection should be performed intra-articularly directly into the knee joint.
• Standard protocol involves one injection per affected joint.
• Procedure should be conducted under strict aseptic conditions by trained healthcare professionals experienced in joint injections.
• Post-injection patient monitoring is recommended to assess tolerance and response.

Ingredient Information

CINGAL® combines two active ingredients for maximum therapeutic effectiveness:

• Hyaluronic Acid (HA): Provides long-term joint lubrication and cushioning, significantly improving joint function.
• Triamcinolone Hexacetonide (Corticosteroid): Quickly reduces inflammation and provides rapid symptom relief.

This dual-action formula effectively addresses both immediate discomfort and sustained joint health.

Storage Instructions

• Store CINGAL® between 2°C and 25°C (36°F to 77°F).
• Protect from direct sunlight, freezing, and excessive moisture.
• Keep in original sealed packaging until ready for use.
• Do not use if the packaging appears compromised or after the expiration date.

Proper storage ensures maximum safety, effectiveness, and reliability.

CINGAL® Contraindications

Avoid use of CINGAL® in patients who:

• Are pregnant or breastfeeding.
• Have known allergies or hypersensitivity to hyaluronic acid, corticosteroids, or other formulation components.
• Present active infections, skin diseases, or open wounds at the intended injection site.
• Suffer from bleeding disorders or those currently on anticoagulant therapy without prior medical consultation.

CINGAL® Precautions and Warnings

• Administer CINGAL® injections exclusively by licensed medical professionals experienced in intra-articular treatments.
• Conduct thorough patient evaluations including medical history, allergies, and current medications.
• Avoid injecting into blood vessels or tissues other than intra-articular spaces to prevent adverse reactions.
• Advise patients clearly about potential side effects and necessary post-treatment care measures.

CINGAL® Manufacturer and Regulatory Information

CINGAL® is manufactured by Anika Therapeutics, a global leader specializing in therapeutic products based on hyaluronic acid technology.

• Fully compliant with European (CE-marked) and international regulatory standards.
• Produced under stringent quality control measures to ensure patient safety and product efficacy.
• Widely trusted by healthcare providers globally for effective osteoarthritis treatment.

Healthcare professionals who order CINGAL from Kinami Health benefit from guaranteed authenticity, premium product quality, and comprehensive professional support, enhancing treatment outcomes and patient satisfaction.